Pharmacogenetics and Proteomics of Anticancer Drugs in Non-Hodgkin's Lymphoma

References

• Clarke, C.A. and Glaser, S.L. (2002) "Changing incidence of non-Hodgkin lymphomas in the United States", Cancer, 94, 2015–2023.
   Web of Science ®Google Scholar
• Danesi, R., De Braud, F., Fogli, S., Di Paolo, A. and Del Tacca, M. (2001) "Pharmacogenetic determinants of anti-cancer drug activity and toxicity", Trends in Pharmacological Sciences, 22, 420–426.
   Google Scholar
• Covell, D.G., Wallqvist, A., Rabow, A.A. and Thanki, N. (2003) "Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data", Molecular Cancer Therapeutics, 2, 317–332.
   Google Scholar
• Tobler, J.B., Molla, M.N., Nuwaysir, E.F., Green, R.D. and Shavlik, J.W. (2002) "Evaluating machine learning approaches for aiding probe selection for gene-expression arrays", Bioinformatics, 18\(Suppl 1), 5164—S171.
   Google Scholar
• Galmarini, C.M., Mackey, J.R. and Dumontet, C. (2002) "Nucleo-side analogues and nucleobases in cancer treatment", Lancet Oncology, 3, 415–424.
   PubMed Web of Science ®Google Scholar
• Molina-Arcas, M., Bellosillo, B., Casado, F.J., Montserrat, E., Gil, J., Colomer, D., et al. (2003) "Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia", Blood, 101, 2328 — 2334.
   Google Scholar
• Sparreboom, A., Danesi, R., Ando, Y., Chan, J. and Figg, W.D. (2003) "Pharmacogenomics of ABC transporters and its role in cancer chemotherapy", Drug Resistance Updates, 6, 71–84.
   Google Scholar
• Gandhi, V. and Plunkett, W. (2002) "Cellular and clinical pharmacology of fludarabine", Clinical Pharmacokinetics, 41, 93 — 103.
   PubMed Web of Science ®Google Scholar
• Dumontet, C., Fabianowska-Majewska, K., Mantincic, D., Callet Bauchu, E., Tigaud, I., Gandhi, V., et al. (1999) "Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562", British Journal of Haematology, 106, 78–85.
   PubMed Web of Science ®Google Scholar
• Hunsucker, S.A., Spychala, J. and Mitchell, B.S. (2001) "Human cytosolic 5'-nucleotidase I. Characterization and role in nucleoside analog resistance", Journal of Biological Chemistry, 276, 10498 — 10504.
   Google Scholar
• Schröder, J.K., Kirch, C., Flasshove, M., Kalweit, H., Seidelmann, M., Hilger, R., et al. (1996) "Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro", Leukemia, 10, 1919–1924.
   Google Scholar
• Loni, L., Del Tacca, M. and Danesi, R. (2001) "Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas", British Journal of Cancer, 85, 1425— 1431.
   Google Scholar
• Venook, A.P., Egorin, M.J., Rosner, G.L., Hollis, D., Mani, S., Hawkins, M., et al. (2000) "Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565", Journal of Clinical Oncology, 18, 2780–2787.
   PubMed Web of Science ®Google Scholar
• Fogli, S., Danesi, R., De Braud, F., De Pas, T., Curigliano, G., Giovannetti, G., et al. (2001) "Drug distribution and pharmacoki-netic-pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer", Annals of Oncology, 12, 1553— 1559.
   Google Scholar
• Beausejour, C.M., Eliopoulos, N., Momparler, L., Le, N.L. and Momparler, R.L. (2001) "Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene", Cancer Gene Therapy, 8, 669 — 676.
   Google Scholar
• Mansson, E., Flordal, E., Liliemark, J., Spasokoukotskaja, T., Elford, H., Lagercrantz, S., et al. (2003) "Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance", Biochemical Phar-macology, 65, 237 — 247
   Google Scholar
• Braess, J., Wegendt, C., Jahns-Streubel, G., Kern, W., Keye, S., Unterhalt, M., et al. (2000) "Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine", British Journal of Haema-tology, 109, 388–395.
   PubMed Web of Science ®Google Scholar
• Zhu, C., Johansson, M. and Karlsson, A. (2000) "The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea", Biochemical Biophysical Re-search Communications, 276, 179 — 182.
   Google Scholar
• Fritzer-Szekeres, M., Salamon, A., Grusch, M., Horvath, Z., Hochtl, T., Steinbrugger, R., et al. (2002) "Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells", Biochemical Pharmacology, 64, 481–485.
   PubMed Web of Science ®Google Scholar
• Giovannetti, E., Mey, V., Danesi, R., et al. (2003) "In vitro synergistic cytotoxicity and modulation of gene expression by gemcitabine and Alimta in lung and pancreatic cancer cells", Proceedings of the American Assocication of Cancer Research, 44, 1071 [abstract 4669].
   Google Scholar
• van der Wilt, CL., Kroep, J.R., Bergman, AM., Loves, W.J., Alvarez, E., Talianidis, I., et al. (2000) "The role of deoxycytidine kinase in gemcitabine cytotoxicity", Advances in Experimental Medicine and Biology, 486, 287 — 290.
   PubMed Web of Science ®Google Scholar
• Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., et al. (1998) "Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue", European Journal of Cancer, 34, 1274 — 1281.
   PubMed Web of Science ®Google Scholar
• Danesi, R., Loni, L., Petrini, M., et al. (2002) "Pharmacogenetics of pyrimidine metabolizing enzymes in non-Hodgkin's lymphomas", Proceedings of the American Assocication of Cancer Research, 43, 321 [abstract 1590].
   Google Scholar
• Reiman, T., Graham, K.A., Wong, J., Belch, A.R., Coupland, R., Young, J., et al. (2002) "Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study", Leukemia 16, 1886— 1887.
   PubMed Web of Science ®Google Scholar
• Hofmann, W.K., de Vos, S., Tsukasaki, K., Wachsman, W., Pinkus, G.S., Said, J.W., et al. (2001) "Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray", Blood, 98, 787–794.
   Google Scholar
• Keszler, G., Szikla, K., Kazimierczuk, Z., Spasokoukotskaja, T., Sasvari-Szekely, M. and Staub, M. (2003) "Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes", Biochemical Pharmacology, 65, 563 — 571.
   PubMed Web of Science ®Google Scholar
• Shirota, Y., Stoehlmacher, J., Brabender, J., Xiong, Y.P., Uetake, H., Danenberg, K.D., et al. (2001) "ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy", Journal of Clinical Oncology, 19, 4298–4304.
   PubMed Web of Science ®Google Scholar
• Pepper, C., Thomas, A., Hidalgo de Quintana, J., Davies, S., Hoy, T. and Bentley, P. (1999) "Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia— the role of Bc12 family dysregula-tion", Leukemia Research, 23, 1007–1114.
   PubMed Web of Science ®Google Scholar
• Feng, L., Achanta, G., Pelican°, H., Zhang, W., Plunkett, W. and Huang, P. (2000) "Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage", International Journal of Molecular Medicine, 5, 597–604.
   PubMed Web of Science ®Google Scholar
• Navaratnam, S., Williams, G.J., Rubinger, M., Pettigrew, N.M., Mowat, M.R., Begleiter, A., et al. (1998) "Expression of p53 predicts treatment failure in aggressive non-Hodgkin's lympho-mas", Leukemia and Lymphoma, 29, 139 — 144.
   PubMed Web of Science ®Google Scholar
• Vose, J.M., Link, BK., Grossbard, ML., Grillo-Lopez, A., Gilman, P., Lowe, A., et al. (2001) "Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma", Jour-nal of Clinical Oncology, 19, 389 — 397.
   Google Scholar
• Greenland, C., Touriol, C., Chevillard, G., Morris, SM., Bai, R., Duyster, J., et al. (2001) "Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis", Oncogene, 20, 7386–7397.
   Google Scholar
• Bishop, C.M. (1995) Neural Networks for Pattern Recognition. Oxford: Clarendon Press.
   Google Scholar
• Azuaje, F. (2001) "A computational neural approach to support the discovery of gene function and classes of cancer", IEEE Transac-tions on Bio-Medical Engineering, 48, 332–339.
   Google Scholar
• Alizadeh, A.A., Eisen, MB., Davis, RE., Ma, C., Lossos, IS., Rosenwald, A., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, 503–511.
   Google Scholar
• Lam, L.T., Pickeral, O.K., Peng, AC., Rosenwald, A., Hurt, EM., Giltnane, J.M., et al. (2001) "Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol", Genome Biology, 2, 1–11.
   Google Scholar
• Smith, DL., Evans, CA., Pierce, A., Gaskell, S.J. and Whetton, A.D. (2002) "Changes in the proteome associated with the action of bcr-abl tyrosine kinase are not related to transcriptional regula-tion", Molecular and Cellular Proteomics, 1, 876–884.
   Google Scholar
• Moller, A., Soldan, M., Volker, U. and Maser, E. (2001) "Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds", Toxicology, 160, 129 — 138.
   Google Scholar
• Tyers, M. and Mann, M. (2003) "From genomics to proteomics", Nature, 422, 193–197.
   Google Scholar
• Poirier, F., Pontet, M., Labas, V., le Caer, J.P., Sghiouar-Imam, N., Raphael, M., et al. (2001) "Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5'-azycytidine", Electrophoresis, 22, 1867 — 1877.
   PubMed Web of Science ®Google Scholar
• Sreekumar, A., Nyati, M.K., Varambally, S., Barrette, T.R., Ghosh, D., Lawrence, T.S., et al. (2001) "Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated pro-teins", Cancer Research, 61, 7585–7593.
   Google Scholar